Acadian Asset Management LLC acquired a new stake in uniQure NV (NASDAQ:QURE) during the second quarter, Holdings Channel reports. The fund acquired 109,033 shares of the company’s stock, valued at approximately $804,000. Acadian Asset Management LLC owned approximately 0.44% of uniQure NV at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. BlackRock Fund Advisors boosted its stake in uniQure NV by 10.5% in the first quarter. BlackRock Fund Advisors now owns 294,118 shares of the company’s stock valued at $3,494,000 after buying an additional 27,903 shares in the last quarter. Landscape Capital Management L.L.C. boosted its position in uniQure NV by 304.2% in the first quarter. Landscape Capital Management L.L.C. now owns 154,100 shares of the company’s stock worth $1,831,000 after buying an additional 115,975 shares during the period. Spark Investment Management LLC boosted its position in uniQure NV by 28.1% in the first quarter. Spark Investment Management LLC now owns 296,000 shares of the company’s stock worth $3,516,000 after buying an additional 64,900 shares during the period. UBS Asset Management Americas Inc. increased its stake in shares of uniQure NV by 5.8% in the first quarter. UBS Asset Management Americas Inc. now owns 345,403 shares of the company’s stock worth $4,103,000 after buying an additional 18,803 shares during the period. Finally, Renaissance Technologies LLC increased its stake in uniQure NV by 95.6% in the first quarter. Renaissance Technologies LLC now owns 205,800 shares of the company’s stock worth $2,445,000 after buying an additional 100,600 shares during the last quarter. 32.38% of the stock is owned by institutional investors and hedge funds.

Shares of uniQure NV (NASDAQ:QURE) traded down 0.51% during mid-day trading on Friday, reaching $7.86. The company’s stock had a trading volume of 130,273 shares. uniQure NV has a 12-month low of $6.68 and a 12-month high of $36.38. The firm’s market cap is $197.51 million. The firm’s 50-day moving average price is $8.14 and its 200 day moving average price is $10.62.

uniQure NV (NASDAQ:QURE) last announced its quarterly earnings results on Thursday, August 25th. The company reported ($0.87) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.89) by $0.02. uniQure NV had a negative return on equity of 61.96% and a negative net margin of 537.62%. On average, analysts expect that uniQure NV will post ($3.71) EPS for the current year.

A number of analysts recently weighed in on the company. Leerink Swann restated an “outperform” rating and issued a $27.00 target price on shares of uniQure NV in a research report on Monday, August 29th. Piper Jaffray Cos. set a $16.00 target price on uniQure NV and gave the stock a “buy” rating in a research report on Friday, August 19th. HC Wainwright assumed coverage on uniQure NV in a research report on Thursday, August 4th. They issued a “buy” rating and a $21.00 target price for the company. Zacks Investment Research downgraded uniQure NV from a “hold” rating to a “sell” rating in a research report on Thursday, August 4th. Finally, Jefferies Group set a $28.00 price target on uniQure NV and gave the stock a “buy” rating in a research note on Thursday, July 28th. One research analyst has rated the stock with a sell rating and ten have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $28.10.

uniQure NV Company Profile

Uniqure NV is a pharmaceutical company based in the Netherlands. It is primarily engaged in the field of gene therapy for orphan diseases. The Company is focused on patients suffering from genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.

5 Day Chart for NASDAQ:QURE

Want to see what other hedge funds are holding QURE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for uniQure NV (NASDAQ:QURE).

Receive News & Ratings for uniQure NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for uniQure NV and related companies with Analyst Ratings Network's FREE daily email newsletter.